Found 12 matching trials
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma PHASE2 The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Learn More & Join Trial
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities PHASE2 This study is a prospective, randomized, single-center randomized controlle...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Lenvatinib and Pembrolizumab Simultaneous Combination Study PHASE2 The efficacy and safety of the use of pembrolizumab in combination with len...
Show More Learn More & Join Trial
A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers PHASE1 The purpose of this single-dose, open-label, sequential, three-period study...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC PHASE2 The treatment options for unresectable HCC have rapidly developed, and immu...
Show More Location
Hunan Provincial People's Hospital(The First Affiliated Hospital of Hunan Normal University)
Learn More & Join Trial
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis PHASE2 This is a single-center, single-arm, open-label study that includes patient...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College
Learn More & Join Trial
A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma PHASE2 Study Design Prospective, single-arm, multicenter clinical study.
Study Dr...
Show More Location
Nanjing Drum Tower Hospital
Learn More & Join Trial
Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC NA This study evaluates a novel "Dual-Conversion" strategy (mechanical volume ...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC PHASE3 The goal of this clinical trial is to compare HAIC concurrently with sequen...
Show More Location
SUN Yat-sen University Cancer Center
Learn More & Join Trial
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis PHASE2 This is a single-center, single-arm, open-label study that includes patient...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College
Learn More & Join Trial